Abstract

This project is to evaluate the safety and immunogenicity of its investigational Shigella conjugate vaccines in an area where shigellosis is common (Phase 2). If Phase 2 study is successful NICHD will evaluate the efficacy of these vaccines (Phase 3) in prevention of dysentry due to S. dysenterlae type 1 and S. flexneri in children.

  Funding Agency

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Research and Development Contracts (N01)
Project #
N01HD073266-000
Application #
2591820
Study Section
Project Start
1997-05-15
Project End
Budget Start
1997-05-15
Budget End
1998-05-15
Support Year
Fiscal Year
1997
Total Cost
Indirect Cost

  Institution

Name
National Institute Hygiene/Epidemiology
Department
Type
DUNS #
555283530
City
Hanoi
State
Country
Vietnam
Zip Code
10000